المؤلفون: Berton, Alessandro Maria, Parasiliti-Caprino, Mirko, Prencipe, Nunzia, Bioletto, Fabio, Lopez, Chiara, Bona, Chiara, Caputo, Marina, Rumbolo, Francesca, Ponzetto, Federico, Settanni, Fabio, Gasco, Valentina, Mengozzi, Giulio, Ghigo, Ezio, Grottoli, Silvia, Maccario, Mauro, Benso, Andrea Silvio

المصدر: Frontiers in Neuroscience. 17

مصطلحات موضوعية: sodium glucose co-transporter type 2 inhibitors, renin-angiotensin-aldosterone system, arginine-vasopressin, bioelectrical impedance vector analysis, extracellular fluid, osmotic homeostasis, General Neuroscience

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b23dcdb66760e17e1dcda0a893afb830Test
https://doi.org/10.3389/fnins.2023.1098404Test

المؤلفون: Andrej Janez, Manfredi Rizzo, Djordje S. Popovic, Anca Pantea Stoian, Nikolaos Papanas, Ali A. Rizvi

المساهمون: Popovic D.S., Papanas N., Pantea Stoian A., Rizvi A.A., Janez A., Rizzo M.

المصدر: Diabetes Therapy

مصطلحات موضوعية: medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), 1 receptor agonists, Sodium-glucose co-transporter , Endocrinology, Diabetes and Metabolism, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), COVID-19, Dipeptidyl peptidase , Review, Type 2 diabetes, Sodium-glucose co-transporter 2 inhibitors, Glucagon-like peptide 1 receptor agonists, Diabetes mellitus, Pandemic, Internal Medicine, medicine, 2 diabetes, Intensive care medicine, Antidiabetic agents, 4 inhibitors, Glucagon-like peptide , business.industry, COVID-19, medicine.disease, Systemic inflammatory response syndrome, Shock (circulatory), Dipeptidyl peptidase 4 inhibitors, medicine.symptom, business, 2 inhibitors, Type 

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5299514d22a08c56c16759e41199dfebTest
https://doi.org/10.1007/s13300-021-01170-3Test

المؤلفون: Rugo, Hope S., Lacouture, Mario E., Goncalves, Marcus D., Masharani, Umesh, Aapro, Matti S., O'Shaughnessy, Joyce A.

المصدر: Breast, Vol 61, Iss, Pp 156-167 (2022)
The Breast : Official Journal of the European Society of Mastology

مصطلحات موضوعية: OGTT, oral glucose tolerance test, Clinical Trials and Supportive Activities, Clinical Sciences, HbA1c, glycosylated hemoglobin, Breast Neoplasms, Review, mTOR, mammalian target of rapamycin, PI3K, phosphatidylinositol-3-kinase, SGLT2i, sodium-glucose co-transporter 2 inhibitor, Alpelisib, Phosphatidylinositol 3-Kinases, AE, adverse events, Breast cancer, PI3Ki, phosphatidylinositol-3-kinase inhibitor, Clinical Research, Antineoplastic Combined Chemotherapy Protocols, IM, intramuscular, Humans, HER2, human epidermal growth factor receptor 2, BID, twice a day, FPG, fasting plasma glucose, FSBG, fingerstick blood glucose, Oncology & Carcinogenesis, RC254-282, Cancer, Prevention, eGFR, estimated glomerular filtration rate, AE management, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, PG, plasma glucose, PIK3CA, General Medicine, GI, gastrointestinal, HR, hazard ratio, TID, thrice daily, SC, subcutaneous, Thiazoles, Public Health and Health Services, PI3Kα, phosphatidylinositol-3-kinase regulatory subunit alpha, Female, Surgery, HR+, hormone receptor-positive, Digestive Diseases, IV, intravenous

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ed100c67c3edaa21648be43be27980eTest
https://doi.org/10.1016/j.breast.2021.12.016Test

المؤلفون: Gronda, Edoardo G., Vanoli, Emilio, Iacoviello, Massimo, Urbinati, Stefano, Caldarola, Pasquale, Colivicchi, Furio, Gabrielli, Domenico

المصدر: Heart Failure Reviews

مصطلحات موضوعية: Sodium-glucose co-transporter 2 inhibitors, Type 2 diabetes mellitus, Cardiovascular death, Heart failure, Cardiology and Cardiovascular Medicine, Article, Renal function

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3535b7c6596a15949ca2e0eeb3604c8aTest
https://doi.org/10.1007/s10741-021-10211-9Test

المؤلفون: Afshin Salsali, João Pedro Ferreira, Mitchell A. Psotka, Martina Brueckmann, Mikhail Kosiborod, Jan Biegus, Adriaan A. Voors, Claudia Grauer, Christiane E. Angermann, John R. Teerlink, Jon Blatchford, Sean P. Collins, Piotr Ponikowski, Michael E. Nassif, Jasper Tromp

المساهمون: Cardiovascular Centre (CVC), University Medical Center Groningen [Groningen] (UMCG), Duke-NUS Medical School [Singapore], National Heart Centre Singapore (NHCS), University of Wrocław [Poland] (UWr), Boehringer Ingelheim Pharma GmbH & Co. KG, Rutgers, The State University of New Jersey [New Brunswick] (RU), Rutgers University System (Rutgers), University Hospital of Würzburg, Boehringer Ingelheim International GmbH, Vanderbilt University Medical Center [Nashville], Vanderbilt University [Nashville], Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Saint Luke's Mid America Heart Institute, University of New South Wales [Sydney] (UNSW), Inova Heart and Vascular Institute, Falls Church, Medizinische Fakultät Mannheim, University of California [San Francisco] (UCSF), University of California, Veterans Affairs Medical Center, San Francisco, California, The EMPULSE trial is funded by the Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance.

المصدر: European Journal of Heart Failure, 23(5), 826-834. Wiley
European Journal of Heart Failure
European Journal of Heart Failure, Oxford University Press (OUP), 2021, ⟨10.1002/ejhf.2137⟩

مصطلحات موضوعية: Sodium-glucose co-transporter 2 inhibitors, Trial design, medicine.medical_specialty, Asia, Acute decompensated heart failure, Heart failure, 030204 cardiovascular system & hematology, Placebo, Sodium–glucose co‐transporter 2 inhibitors, 03 medical and health sciences, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Sodium-Glucose Transporter 2, glucose co‐, Diabetes mellitus, Internal medicine, Empagliflozin, medicine, Humans, In patient, Sodium–, Study Design, Ejection fraction, business.industry, Sodium, Stroke Volume, medicine.disease, 3. Good health, Europe, Glucose, Kansas City Cardiomyopathy Questionnaire, North America, Cardiology and Cardiovascular Medicine, business, transporter 2 inhibitors

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8002ded798854384daa4260943d936eaTest
https://doi.org/10.1002/ejhf.2137Test

المؤلفون: Abhinav Karan, Stanley Giddings, Gabriella Grimaldos, Sangeeta Persad, Sadi Raza, Rajeev Seecheran, Antonio Tello-Montoliu, Aleena Ishmael, Darren Dookeeram, Kabeer Ali, Harun Abdullah, Srivane Richard, Naveen Seecheran, Lakshmipathi Peram, Kathryn Grimaldos, Shastri Motilal, David J. Schneider, Valmiki Seecheran, Ceylon Gomes

المصدر: Cardiology and Therapy

مصطلحات موضوعية: Aspirin, medicine.medical_specialty, business.industry, Urology, Dapagliflozin, Sodium-glucose co-transporter 2 inhibitor (SGLT2i), Clopidogrel, medicine.disease, Confidence interval, Coronary artery disease, chemistry.chemical_compound, Regimen, chemistry, Pharmacodynamics, VerifyNow™, medicine, Platelet function, Platelet reactivity, Cardiology and Cardiovascular Medicine, Adverse effect, business, Original Research, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c03472f5a721588eaa446fb0f948b0f3Test
https://doi.org/10.1007/s40119-021-00242-6Test

المؤلفون: Beata Jacuś, Mirosława Kowalkowska, Paweł Miękus, Grzegorz Grześk

المصدر: Farmacja Polska, Vol 77, Iss 8, Pp 516-521 (2021)

مصطلحات موضوعية: Pharmacology, medicine.medical_specialty, sodium glucose co-transporter inhibitors, Urinary infection, type 2 diabetes mellitus, business.industry, Sodium, Pharmaceutical Science, chemistry.chemical_element, Transporter, Gastroenterology, cardiovascular diseases, chronic heart failure, RS1-441, Clinical Practice, genito-urinary infections, Pharmacy and materia medica, chemistry, Internal medicine, medicine, business, Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4cbfd45247d79d3473ffeb0a895dd8cTest
https://doi.org/10.32383/farmpol/143033Test

المؤلفون: Edoardo Gronda, Massimo Iacoviello, Claudio Napoli, Pasquale Caldarola, Domenico Gabrielli, Furio Colivicchi, Stefano Urbinati, Edoardo Mannucci

المصدر: European Heart Journal Supplements : Journal of the European Society of Cardiology

مصطلحات موضوعية: Sodium-glucose co-transporter 2 inhibitors, medicine.medical_specialty, Heart failure, chemistry.chemical_compound, Diabetes mellitus, Internal medicine, Type 2 diabetes mellitus, medicine, Empagliflozin, AcademicSubjects/MED00200, Dapagliflozin, Canagliflozin, Ejection fraction, business.industry, Type 2 Diabetes Mellitus, Articles, medicine.disease, chemistry, Cardiovascular death, Cardiology, Cardiology and Cardiovascular Medicine, business, Renal function, medicine.drug, Kidney disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2694f6672d64d5a4a407e85ca7efc4c8Test
https://doi.org/10.1093/eurheartj/suab066Test

المؤلفون: Carla Iacobini, Martina Vitale, Jonida Haxhi, Carlo Pesce, Giuseppe Pugliese, Stefano Menini

المصدر: Antioxidants (Basel, Switzerland). 11(11)

مصطلحات موضوعية: reactive oxygen species, sodium glucose co-transporter 2 inhibitors, Physiology, advanced glycation end products, atherosclerosis, diabetic kidney disease, inflammation, methylglyoxal, prolyl hydroxylase domain proteins, sirtuin-1, Warburg effect, Clinical Biochemistry, Cell Biology, Biochemistry, Molecular Biology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f6dfa8bf5989467eb17fd593f5d77d1Test
https://pubmed.ncbi.nlm.nih.gov/36358555Test

المؤلفون: Stuart J. Pocock, Daniel Cotton, Martina Brueckmann, Stefan D. Anker, James L. Januzzi, Gerasimos Filippatos, Waheed Jamal, Milton Packer, João Pedro Ferreira, Javed Butler, Tomoko Iwata, Faiez Zannad

المساهمون: BOZEC, Erwan, Baylor Heart and Vascular Institute, Baylor University Medical Center, Imperial College London, Division of Cardiology, Harvard Medical School and Massachusetts General Hospital, Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin, Department of Medicine, University of Mississippi School of Medicine, National and Kapodistrian University of Athens (NKUA), Department of Medical Statistics, London School of Hygiene and Tropical Medicine, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim, Eli Lilly and Company.

المصدر: European Journal of Heart Failure
European Journal of Heart Failure, European Society of Cardiology (Wiley), 2021, 23 (9), pp.1529-1538. ⟨10.1002/ejhf.2256⟩

مصطلحات موضوعية: medicine.medical_specialty, New York Heart Association Class, Empagliflozin, Renal function, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Glucosides, Troponin T, Diabetes mellitus, Internal medicine, medicine, Sodium-glucose co-transporter 2 inhibition, Humans, Benzhydryl Compounds, Heart Failure, Ejection fraction, biology, business.industry, Stroke Volume, Atrial fibrillation, Prognosis, medicine.disease, Troponin, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Heart failure, Cardiology, biology.protein, Cardiology and Cardiovascular Medicine, business, Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02d7d06292ba1b4e6819c2c2708d9739Test
https://doi.org/10.1002/ejhf.2256Test